Human Formulations

Flavoxate 20 mg Film-Coated Tablet IP

Flavoxate 20 mg Film-Coated Tablet IP is a film-coated tablet formulated with 20 mg. The active ingredient profile is Flavoxate, placing the product in the urinary antispasmodic category. Flavoxate is a urinary antispasmodic used for symptomatic relief of

TabletsBeta-Lactam Tablets Single Ingredient Film-Coated Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Tablets, Beta-Lactam Tablets
Dosage Form
Film-Coated Tablet
Product Type
Single Ingredient

Available strengths

20 mg

Description

Flavoxate 20 mg Film-Coated Tablet IP is a film-coated tablet formulated with 20 mg. The active ingredient profile is Flavoxate, placing the product in the urinary antispasmodic category. Flavoxate is a urinary antispasmodic used for symptomatic relief of bladder and urinary-tract muscle spasm; it is not an antibacterial agent. The film coating provides a finished oral solid-dosage presentation and may help with handling and product acceptability. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured